GB9718616D0 - Oral vaccine - Google Patents

Oral vaccine

Info

Publication number
GB9718616D0
GB9718616D0 GBGB9718616.7A GB9718616A GB9718616D0 GB 9718616 D0 GB9718616 D0 GB 9718616D0 GB 9718616 A GB9718616 A GB 9718616A GB 9718616 D0 GB9718616 D0 GB 9718616D0
Authority
GB
United Kingdom
Prior art keywords
oral vaccine
vaccine
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9718616.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Priority to GBGB9718616.7A priority Critical patent/GB9718616D0/en
Publication of GB9718616D0 publication Critical patent/GB9718616D0/en
Priority to PCT/GB1998/002631 priority patent/WO1999011284A1/en
Priority to AU88779/98A priority patent/AU8877998A/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/105Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2220/00Biochemical treatment
    • A23C2220/20Treatment with microorganisms
    • A23C2220/202Genetic engineering of microorganisms used in dairy technology
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
GBGB9718616.7A 1997-09-02 1997-09-02 Oral vaccine Ceased GB9718616D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9718616.7A GB9718616D0 (en) 1997-09-02 1997-09-02 Oral vaccine
PCT/GB1998/002631 WO1999011284A1 (en) 1997-09-02 1998-09-02 Oral vaccine
AU88779/98A AU8877998A (en) 1997-09-02 1998-09-02 Oral vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9718616.7A GB9718616D0 (en) 1997-09-02 1997-09-02 Oral vaccine

Publications (1)

Publication Number Publication Date
GB9718616D0 true GB9718616D0 (en) 1997-11-05

Family

ID=10818424

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9718616.7A Ceased GB9718616D0 (en) 1997-09-02 1997-09-02 Oral vaccine

Country Status (3)

Country Link
AU (1) AU8877998A (en)
GB (1) GB9718616D0 (en)
WO (1) WO1999011284A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1084709A1 (en) * 1999-09-17 2001-03-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Oral recombinant lactobacilli vaccines
ATE503838T1 (en) * 2003-10-28 2011-04-15 Friesland Brands Bv SITE-SPECIFIC ADMINISTRATION OF ACTIVE SUBSTANCES IN THE INTESTINAL
KR102390694B1 (en) * 2021-07-13 2022-04-29 한국식품연구원 Composition for preventing, improving or treating cancer comprising the Lactiplantibacillus paraplantarum WiKim0130

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3553065B2 (en) * 1992-12-30 2004-08-11 バイオテクノロジスク インスティテュート Recombinant lactic acid bacterium containing inserted promoter and method for constructing the same
EP0654273A1 (en) * 1993-11-18 1995-05-24 Harry H. Leveen Pharmaceutical product and method for treatment
WO1996033732A1 (en) * 1995-04-28 1996-10-31 Oravax, Inc. Multimeric, recombinant urease vaccine

Also Published As

Publication number Publication date
AU8877998A (en) 1999-03-22
WO1999011284A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
PL341761A1 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
EP1020193A4 (en) Oral preparation
IL140094A0 (en) Vaccine
IL139467A0 (en) Vaccine
GB9718616D0 (en) Oral vaccine
ZA982763B (en) Vaccines
GB9625968D0 (en) Vaccine
GB9807805D0 (en) Vaccine
GB9820956D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9717423D0 (en) Vaccine
GB9718902D0 (en) Vaccine
GB9720982D0 (en) Vaccine
GB9812228D0 (en) Vaccine
GB9802544D0 (en) Vaccine
GB9822703D0 (en) Vaccine
GB9805961D0 (en) Vaccine
GB9811954D0 (en) Vaccine
GB9807933D0 (en) Vaccine
GB9822709D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)